Home/ Understanding MCL/ Understanding Your Diagnosis
Understanding MCL

Understanding Your Diagnosis

What your mantle cell lymphoma pathology report means.

After a biopsy confirms Mantle Cell Lymphoma (MCL), your doctor will receive a pathology report. This document contains important information about the characteristics of your disease. For many patients, the terminology in these reports can feel confusing or overwhelming. Understanding a few key elements can help you feel more confident during discussions with your medical team.

Confirming Mantle Cell Lymphoma

Most MCL diagnoses are confirmed through a lymph node biopsy or tissue sample. Pathologists examine the sample under a microscope and perform specialized testing to identify features unique to mantle cell lymphoma.

A hallmark of MCL is the presence of a genetic change involving the cyclin D1 gene, often caused by a chromosomal translocation known as t(11;14). This finding helps distinguish MCL from other types of lymphoma.

Key Features in Your Pathology Report

Ki-67 Proliferation Index

Ki-67 measures how quickly lymphoma cells are dividing. Higher numbers generally indicate that the lymphoma is growing more rapidly. Your doctor may use this information when considering treatment options.

TP53 Mutation

TP53 is a gene that helps regulate how cells repair damage. When this gene is altered, the lymphoma may behave more aggressively and respond differently to certain treatments. Testing for TP53 mutations has become increasingly important in guiding treatment decisions.

MCL Variants

Your report may describe the appearance of the lymphoma cells under a microscope. These descriptions help doctors understand how the disease may behave.

Variants you may see in your report
Classic Mantle Cell Lymphoma
The most common presentation. Cells have a characteristic appearance under the microscope.
Blastoid variant
Cells resemble lymphoblasts. Associated with more aggressive behavior.
Pleomorphic variant
Cells appear highly irregular in size and shape. Also associated with more aggressive behavior.

Staging

After diagnosis, additional tests such as PET scans, CT scans, or bone marrow biopsies may help determine how widely the lymphoma has spread. This process is called staging and helps guide treatment planning.

When to Consider a Second Pathology Review

Consider a specialist review

Because Mantle Cell Lymphoma is rare, some patients choose to have their biopsy reviewed by a pathologist who specializes in lymphomas at a major cancer center. This can provide additional confidence in the diagnosis and ensure that all important markers have been evaluated.

Questions to Ask Your Doctor

Questions you may want to ask
  • What subtype of MCL do I have?
  • What is my Ki-67 score?
  • Was TP53 testing performed?
  • Should my biopsy be reviewed by a lymphoma specialist?

Understanding your pathology report can help you feel more informed and prepared as you move forward.

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.